​

Zymeworks (ZYME) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ZYME Stock Forecast

Zymeworks (ZYME) stock forecast, based on 21 Wall Street analysts, predicts a 12-month average price target of $40.50, with a high of $48.00 and a low of $31.00. This represents a 77.17% increase from the last price of $22.86.

$5 $14 $23 $32 $41 $50 High: $48 Avg: $40.5 Low: $31 Last Closed Price: $22.86

ZYME Stock Rating

Zymeworks stock's rating consensus is Buy, based on 21 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 19 Buy (90.48%), 2 Hold (9.52%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 21 0 2 19 Strong Sell Sell Hold Buy Strong Buy

ZYME Price Target Upside V Benchmarks

TypeNameUpside
StockZymeworks77.17%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts2412
Avg Price Target$34.00$35.50$35.25
Last Closing Price$22.86$22.86$22.86
Upside/Downside48.73%55.29%54.20%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 26210---12
Jun, 26212---14
May, 26212---14
Apr, 26212---14
Mar, 26212---14
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 07, 2026Truist Financial$31.00$26.4517.20%35.61%
Jun 30, 2026Wells Fargo$37.00$24.1053.53%61.85%
Jun 09, 2026Gregory RenzaTruist Financial$28.00$23.9317.01%22.48%
Jun 03, 2026Andrew BerensH.C. Wainwright$46.00$24.1190.79%101.22%
Mar 09, 2026Evercore ISI$48.00$24.2597.94%109.97%
Dec 17, 2025Asthika GoonewardeneTruist Financial$40.00$25.8554.74%74.98%
Dec 12, 2025Wells Fargo$33.00$24.9332.37%44.36%
Dec 03, 2025JMP Securities$32.00$25.1027.49%39.98%
Nov 19, 2025Eva VerdejoWells Fargo$25.00$22.998.74%9.36%
Nov 19, 2025Stephen WilleyStifel Nicolaus$40.00$22.9973.99%74.98%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 30, 2026Wells FargoOverweightOverweighthold
Jun 30, 2026CitigroupBuyBuyhold
Jun 29, 2026B. RileyPositivePositivehold
Jun 03, 2026H.C. WainwrightBuyBuyhold
Dec 12, 2025Wells FargoCautiousOverweightupgrade
Dec 03, 2025CitigroupBuyOutperforminitialise
Nov 21, 2025B. RileyBuyBuyhold
Nov 19, 2025Wells FargoCautiousCautioushold
Oct 27, 2025H.C. WainwrightBuyBuyhold
Oct 14, 2025H.C. WainwrightBuyBuyupgrade

Financial Forecast

EPS Forecast

$-10 $-7 $-4 $-1 $2 $5 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-4.06$1.91$-1.72$-1.62$-1.08---
Avg Forecast$-4.55$-0.06$-1.96$-1.44$-1.75$-1.17$-1.91$-1.04
High Forecast$-1.48$-0.03$-1.75$-1.30$-1.10$0.64$-0.98$-0.46
Low Forecast$-9.56$-0.10$-2.29$-1.81$-2.20$-2.10$-3.06$-1.56
Surprise %-10.77%-3283.33%-12.24%12.50%-38.29%---

Revenue Forecast

$-50M $50M $150M $250M $350M $450M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$26.68M$412.48M$76.01M$76.30M$-27.11M---
Avg Forecast$15.63M$240.59M$74.79M$89.49M$84.38M$160.95M$156.89M$196.94M
High Forecast$28.84M$370.44M$81.28M$114.37M$112.26M$160.98M$217.23M$272.69M
Low Forecast$7.52M$143.38M$71.60M$72.84M$49.90M$160.92M$89.68M$112.57M
Surprise %70.74%71.44%1.64%-14.73%-132.13%---

Net Income Forecast

$-20B $-15B $-10B $-5B $0 $5B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-211.84M$124.34M$-118.67M$-122.69M$-19.66B---
Avg Forecast$-254.98M$-280.48M$-118.67M$-113.67M$-116.02M$-69.54M$-166.65M$-71.62M
High Forecast$-203.99M$-224.39M$-94.94M$-89.37M$-75.99M$44.04M$-67.49M$-31.73M
Low Forecast$-305.98M$-336.58M$-142.41M$-124.36M$-151.24M$-144.71M$-210.72M$-107.42M
Surprise %-16.92%-144.33%-7.94%16847.80%---

ZYME Forecast FAQ

Is Zymeworks stock a buy?

Zymeworks stock has a consensus rating of Buy, based on 21 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 19 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Zymeworks is a favorable investment for most analysts.

What is Zymeworks's price target?

Zymeworks's price target, set by 21 Wall Street analysts, averages $40.5 over the next 12 months. The price target range spans from $31 at the low end to $48 at the high end, suggesting a potential 77.17% change from the previous closing price of $22.86.

How does Zymeworks stock forecast compare to its benchmarks?

Zymeworks's stock forecast shows a 77.17% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Zymeworks over the past three months?

  • July 2026: 16.67% Strong Buy, 83.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 14.29% Strong Buy, 85.71% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 14.29% Strong Buy, 85.71% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Zymeworks’s EPS forecast?

Zymeworks's average annual EPS forecast for its fiscal year ending in December 2026 is $-1.17, marking a 8.33% increase from the reported $-1.08 in 2025. Estimates for the following years are $-1.91 in 2027, and $-1.04 in 2028.

What is Zymeworks’s revenue forecast?

Zymeworks's average annual revenue forecast for its fiscal year ending in December 2026 is $160.95M, reflecting a -693.69% decrease from the reported $-27.11M in 2025. The forecast for 2027 is $156.89M, and $196.94M for 2028.

What is Zymeworks’s net income forecast?

Zymeworks's net income forecast for the fiscal year ending in December 2026 stands at $-69.542M, representing a -99.65% decrease from the reported $-19.664B in 2025. Projections indicate $-167M in 2027, and $-71.618M in 2028.